1. Introduction {#s0005}
===============

Fluctuations of estradiol and progesterone during natural menstrual cycles are fundamental in synchronizing cellular activities. In the periphery, sex hormone oscillations synchronize differentiation of ovarian follicles with epithelial maturation in uterus. In the central nervous system, changes in sex hormones are captured in changes in neuronal architecture, excitability, and cognitive processes ([@bib27]). In women, volume increase in areas of the temporal lobe correlates with elevated estradiol levels ([@bib32; @bib30; @bib10]). Estradiol and progesterone are potent neuromodulators. In general, estradiol increases and progesterone decreases neuronal excitability ([@bib11]). Furthermore, estradiol or menstrual cycle phases having elevated levels of estradiol correlate positively with performance in verbal memory tasks, working memory, paired-associate learning, but negatively with performance in spatial tasks ([@bib16; @bib29; @bib15; @bib17; @bib36; @bib24]).

Ovarian steroid hormone fluctuations correlate with changes in energy balance in reproductively fertile women. In comparison to the follicular phase, energy expenditure and food intake is increased in the luteal phase ([@bib7]). Nutritional and endocrinological studies on rodents, non-human primates and humans revealed that estradiol has an inhibitory impact on food intake ([@bib7]). Although the weight of the brain is 2% of the total body weight, it consumes about 20% of the energy. Task processing increases energy consumption only by about 5% ([@bib34]). Critically, more than 90% of cortical neurons are glutamatergic ([@bib6]), and the great majority of energy in the human brain is presumably consumed by excitatory glutamatergic synapses ([@bib3; @bib34]). Synchronized oscillatory activity monitored by the EEG during event related potentials or spontaneous, intrinsic activity is related to synaptic activity ([@bib8]). Interestingly, Hans Berger, who described alpha oscillations for the first time, concluded already in 1929 that "... mental work ... adds only a small increment to the cortical work which is going on continuously ..." ([@bib5; @bib34]). Considering that the majority of energy is consumed in the resting -- but awake -- brain at glutamatergic synapses, EEG signals represent synchronous activity of glutamatergic synapses, and fluctuations in ovarian steroid hormones determine energy expenditure and food intake in women, we assumed that the frequency of ongoing alpha oscillations is related to the level of estradiol or progesterone.

Women using oral contraceptives differ in their response to specific tasks as well as in their resting state from women having a natural menstrual cycle. Compared to women with a natural menstrual cycle, women using oral contraceptives show a stronger BOLD response to faces in the right fusiform face area ([@bib25]), but a smaller BOLD response to erotic stimuli in the left precentral gyrus ([@bib1]). In a numerical task, women using oral contraceptives have a BOLD response similar to men ([@bib31]). Critically, Petersen and colleagues describe that oral contraceptives as well as endogenous sex hormones are associated with a decrease in connectivity in the resting state network ([@bib28]). Furthermore, recent voxel-based morphometric studies revealed some areas in the frontal and temporal lobe that were larger in women using oral contraceptives compared to women having a natural menstrual cycle ([@bib30; @bib10]).

Alpha oscillations (8--12 Hz) are the dominant frequency band in the human EEG ([@bib20]). Typically, amplitude of the alpha rhythm is largest with the eyes closed and attenuates when eyes are opened. Accordingly, this alpha desynchronization was interpreted as suppression of sensory input or event-related desynchronization. However, more recently, alpha oscillations are seen as functional as well as physiological inhibition ([@bib20; @bib21]). In addition [@bib2] pointed out that alpha frequency is positive correlated with intelligence, a finding that has been replicated recently correlating individual alpha frequency and general intelligence *g* ([@bib12]).

The aims of the present study were to evaluate the frequency of alpha oscillations in resting state conditions (1) across the menstrual cycle, (2) in relation to endogenous estradiol or progesterone, and (3) in the active and inactive phase of oral contraceptive use.

2. Results {#s0010}
==========

2.1. Alpha oscillations in resting state conditions have a higher frequency in luteal compared to follicular women {#s0015}
------------------------------------------------------------------------------------------------------------------

To evaluate whether frequency of ongoing EEG was menstrual cycle-dependent we (1) calculated IAF and center frequency as detailed in [Experimental procedures](#s0035){ref-type="sec"} and (2) compared IAF and center frequency in women who participated in three segregated experiments ([Tables 1 and 2](#t0005 t0010){ref-type="table"}). [Figs. 1 and 2](#f0005 f0010){ref-type="fig"} summarize center frequency and IAF of ongoing EEG in the left and right parieto-occipital cortex. In each of the studies, we identified the slowest center frequency in the late follicular phase and the fastest in the luteal phase. Repeated measures ANOVA, calculated for each study showed a significant difference between cycle phases for Po4 center frequency in study 1 (*F*~(2,\ 34)~=49.235, *p*=.000, *η*^2^=.743), study 2 (*F*~(2,\ 36)~=54.147, *p*=.000, *η*2=.751) and study 3 (*F*~(2,\ 36)~=73.849, *p*=.000, *η*2=.804). ANOVAs for Po3, P3 and P4 electrodes revealed similar results. As expected, dependent *t*-tests yielded that women showed significant faster center frequency in the luteal phase compared to late follicular phase in study 1 (Po4 *t*~(17)~=−8.913, *p*=.000), study 2 (Po4 *t*~(18)~=−9.476, *p*=.000), and study 3 (Po4 *t*~(18)~=−10.450, *p*=.000). Center frequency increased by 2--5% (by .1--.5 Hz) from late follicular to luteal phase. Similarly, women showed faster center frequency in the luteal phase compared to early follicular phase in study 1(P3 *t*~(17)~=−12.866, *p*=.000), study 2 (P3 *t*~(18)~=−11.604, *p*=.000) and study 3 (Po4 *t*~(18)~=−8.663, *p*=.000). Repeated measures ANOVA showed a significant difference between cycle phases for P3 IAF in study 2 (*F*~(2,\ 36)~=4.253, *p*=.037, *η*2=.191) but not in study 1 (*F*~(2,\ 34)~=1.721, *p*=.207, *η*^2^=.092) and study 3 (*F*~(2,\ 36)~=.557, *p*=.520, *η*^2^=.030). ANOVAs for Po3, P3 and P4 electrodes revealed similar results. Dependent *t*-tests showed that IAF was faster in luteal compared to late follicular women in study 1 (P3 *t*~(17)~=−3.562, *p*=.002), study 2 (P3 *t*~(18)~=−2.241, *p*=.038), but not in study 3. Center frequency revealed more significant associations than IAF ([Figs. 1 and 2](#f0005 f0010){ref-type="fig"}). However, we identified a positive correlation between IAF and center frequency in all three studies for women having a natural menstrual cycle as well as for women using hormonal contraceptives (*p*\<.05). For example, in early follicular women IAF (Po3) and center frequency (Po3) correlated positively in study 1 (*r*~(16)~=.672, *p*=.002), in study 2 (*r*~(17)~=.705, *p*=.001), and study3 (*r*~(17)~=.714, *p*=.001). Therefore, the reason why we got statistically significant results preferentially for center frequency compared to IAF is due to the high variance in IAF.

2.2. IAF and center frequency are negatively correlated with estradiol in women having a natural menstrual cycle {#s0020}
----------------------------------------------------------------------------------------------------------------

Because of the significant association between IAF and center frequency with menstrual cycle phase, we next correlated estradiol and progesterone level with alpha frequency. In general, we found that estradiol was negatively correlated with IAF and with center frequency ([Fig. 3](#f0015){ref-type="fig"}).

IAF correlated negatively with estradiol in luteal phase in study 1 (P4 *r*~(15)~=−.415, *p*=.098) and study 2 (P4 *r*~(15)~=−.483, *p*=.049) as well as in late follicular phase in study 1 (P3 *r*~(15)~=−.468, *p*=.058) and study 3 (P4 *r*~(16)~=−.608, *p*=.007). Similarly, center frequency correlated negatively with estradiol in luteal phase in study 1 (P4 *r*~(15)~=−.683, *p*=.003), in late follicular phase in study 1 (P4 *r*~(15)~=−583, *p*=.014) and study 3 (P4 *r*~(16)~=−.501, *p*=.034), as well as in early follicular phase in study 1 (P4 *r*~(16)~=−503, *p*=.033). In parietal and parieto-occipital electrodes, the significance of negative correlations between estradiol level and center frequency varied between *p*=.003 and *p*=.098. In contrast to estradiol, we did not detect significant correlations (*p*\<.05) between progesterone and IAF or center frequency.

2.3. Oral contraceptives and alpha oscillations {#s0025}
-----------------------------------------------

In oral contraceptive users in the active phase, Po3 center frequency ranges between 9.64 and 11.12 Hz with an average of 10.27±.37 (*n*=57), and in the inactive phase between 9.33 and 10.85 Hz with an average of 10.05±.31 (*n*=57). In general, center frequency, but not IAF, revealed a significant faster frequency in the active compared to inactive phase of oral contraceptive use ([Fig. 1](#f0005){ref-type="fig"}) in study 1 (P3 *t*~(17)~=8.961, *p*=.000), study 2 (P3 *t*~(19)~=4.217, *p*=.000), and study 3 (P3 *t*~(19)~=11.315, *p*=.000). Thus, the impact of oral contraceptives on alpha frequency was reversible within a few days.

In study 2 and 3, the center frequency recorded from parieto-occipital cortex was smaller in women using oral contraceptives (active phase) than in women in the luteal phase (study 2: Po3 *t*~(33)~=6.608, *p*=.000; study 3: Po4 *t*~(37)~=4.522, *p*=.000), but faster than in late follicular women in study 2 (P3 *t*~(37)~=−4.491, *p*=.000). In study 1, women using oral contraceptives (active phase) had a higher center frequency compared to women in the luteal phase (P4 *t*~(33)~=−8.850, *p*=.000). However, in this study, women having a natural menstrual cycle revealed slower center frequency or IAF compared to women in study 2 and study 3 ([Figs. 1 and 2](#f0005 f0010){ref-type="fig"}). Whether differences in alpha frequencies are related to external factors, like seasonal differences ([Tables 1 and 2](#t0005 t0010){ref-type="table"}), remains to be evaluated. Comparison of oral contraceptive-free interval revealed similar results. When we used IAF, we identified a higher IAF during active phase compared to luteal phase in study 1 (P3 *t*~(33)~=−2.187, *p*=.036), but a lower IAF during inactive phase compared to luteal phase in study 3 (Po4 *t*~(37)~=2.281, *p*=.028).

Women using hormonal contraceptives (active phase) are characterized by significantly lower estradiol concentration than normally cycling women during late follicular phase (*t*~(32)~=1.991, *p*=.055) and luteal phase (*t*~(32)~=2.062, *p*=.047) in study 1, during early follicular (*t*~(35)~=2.058, *p*=.047), late follicular (*t*~(34)~=4.912, *p*=.000) and luteal phase (*t*~(34)~=3.094, *p*=.004) in study 2. In contrast to women having a natural menstrual cycle, women using oral contraceptives did not reveal an association between estradiol and alpha frequency (*p*\>.05) in active and inactive phase.

3. Discussion {#s0030}
=============

Our confirmation of previous EEG findings ([@bib4; @bib9]) in three independent studies demonstrates a robust effect of menstrual cycle on alpha frequency. In addition, we identified a negative correlation between estradiol and frequency of the alpha band. This provides a further hint of the interplay between neural activity and endocrine system. Furthermore, similar to the results of Becker and colleagues ([@bib4]), we find that women using oral contraceptives have an alpha frequency close to early follicular women.

The brain is not a reflexive organ, but intrinsically active. Raichle and colleagues defined a default mode by comparing deviations in the local oxygen extraction fraction with mean hemisphere oxygen extraction fraction ([@bib35]). These authors identified brain areas tonically active in a baseline state along midline areas, including precuneus, posterior cingulate, and medial prefrontal cortex, as well as in some lateral areas, specifically in parietal cortex. A default system, which is task-independently active, has since then been identified in numerous fMRI and PET studies ([@bib34]). The earliest electrophysiological documentation of intrinsic brain activity dates back to 1929, when Hans Berger published ongoing alpha activity in awake but resting individuals with eyes closed ([@bib5]). We as well as Creutzfeldt and colleagues ([@bib4; @bib9]) demonstrate reliable cyclic changes in alpha frequencies in women. Since resting alpha frequency is a predictor for cognitive performance ([@bib12]), menstrual cycle-dependent changes in alpha activity may have functional consequences in performance.

Elevated estradiol correlates with a higher spine density in hippocampal pyramidal neurons in rodents and non-human primates and an increased synaptic excitatory potential in rodents ([@bib26; @bib27]). Surprisingly, we identified a negative correlation between estradiol and alpha frequency. This may indicate that these neuroanatomical and physiological findings are more related to EEG amplitudes rather than frequency or to different frequency bands compared to alpha band. Interestingly, an association between low estradiol and fast alpha frequency was also detectable in our study in two participants where menstruation failed to occur at least in the last twelve months. In general, these women had high IAF. One woman showed on both EEG sessions a high IAF of 11.48 Hz and 12.45 Hz, and the second an IAF of 10.99 and 8.06 Hz, respectively. Changes in alpha frequency during the menstrual cycle may be related to the modulatory impact of estradiol and progesterone on synaptic transmission. Noticeably, alpha frequency is lower in late follicular phase compared to early follicular phase or luteal phase. Early follicular phase and luteal phase have in common that levels of estradiol or progesterone are either low (early follicular phase) or high (luteal phase), but the ratio of estradiol to progesterone is similar. In the late follicular phase, the level of estradiol is elevated, but the level of progesterone is low. Thus, the ratio of estradiol to progesterone is high in the late follicular phase. Cyclic changes in sex steroids are paralleled by changes in gene expression in the nervous system. Interestingly, estradiol modulates expression of GABA A receptors as well as glutamate decarboxylase. GABA A receptors are upregulated in proestrus rats, where estradiol is elevated ([@bib33]). Furthermore, the *gad*2 promotor, required for expression of glutamate decarboxylase, is a target of estradiol receptors ([@bib18]). GABAergic synaptic transmission is modulated by progesterone and its metabolites. Accordingly, estradiol-dependent expression of GABA A receptors and the GABA synthesizing enzyme, glutamate decarboxylase, may affect alpha frequency. The modulation of GABAergic transmission may be different when the ratio of estradiol to progesterone is similar, like in early follicular phase and luteal phase, or when the ratio is high, like in the late follicular phase.

Changes in frequency of ongoing alpha oscillations ([@bib4], present study) and food intake ([@bib23; @bib7]) across the menstrual cycle are in parallel. These studies demonstrate a decrease in food intake during the periovulatory, but an increase in the luteal phase. Our study reveals a decrease in alpha frequency in the late follicular phase compared to the luteal phase. We suggest that this similarity is beyond chance. The human brain weighs 2% of the total body weight, but consumes 20% of the bodies resting energy budget ([@bib34]). More than 90% of cortical synapses are glutamatergic ([@bib6]). In the human brain, glutamatergic synapses are the dominant ATP consumers with an estimated 60% to 80% of the energy used by intrinsic brain activity ([@bib3; @bib34]). Accordingly, increase in glutamatergic activity predicts accelerated ATP consumption. If an increase in estradiol is coupled to a decrease in food consumption, a decline in alpha frequency saves energy because synapses are activated less frequently. Interestingly, although estradiol to progesterone ratio changes between late follicular phase and luteal phase, estradiol does not vary that much between these menstrual cycle phases. Individuals low in estradiol have higher IAF and center frequency compared to women high in estradiol. Accordingly, these individuals should differ in metabolism. In preliminary results, we found in the luteal phase a positive correlation between body temperature and center frequency (*r*~(19)~=.451, *p*=.053). Although many women taking a combination pill complain about weight gain as an adverse side effect, meta-studies on this topic did not find empirical evidence ([@bib14; @bib22]). Nevertheless, correlative studies between brain and body metabolism in women using oral contraceptives would be of interest to identify the impact of ethinyl estradiol, a synthetic steroid in hormonal contraceptives, on neural activity.

Structure and activity of the brain of women using oral contraceptives differ from those women having a natural menstrual cycle ([@bib30; @bib10; @bib31]). Critically, differences between oral contraceptive users and non-users are detectable under resting state conditions of the brain. Petersen and colleagues describe a decrease in connectivity in oral contraceptive users and luteal women, suggesting the synthetic hormones in oral contraceptives and endogenous sex hormones have a similar effect on connectivity in the resting state ([@bib28]). In the present study, we find a similar alpha frequency in oral contraceptive users and early follicular women. If ethinyl estradiol substitute endogenous, consumption of oral contraceptives predict a decrease in center frequency or IAF. Similarity in alpha frequency in oral contraceptive users and early follicular women indicate that either ethinyl estradiol is not as efficient as endogenous estradiol in decreasing alpha frequency or combination of ethinyl estradiol and progestins have an enhancing effect on alpha frequency.

In conclusion, our study demonstrates that menstrual cycle phase and, specifically, estradiol correlates with alpha frequency. Given the importance of menstrual cycle and sex-hormone associated differences in cognitive tasks ([@bib16; @bib29; @bib15; @bib17; @bib36; @bib24]) and the predictor capacity of alpha frequency on task performances ([@bib12]), modulation of ongoing oscillations by estradiol may be a link between performance and sex hormone changes.

4. Experimental procedures {#s0035}
==========================

4.1. Participants {#s0040}
-----------------

EEG recordings were collected from three subject groups (see [Tables 1 and 2](#t0005 t0010){ref-type="table"}). Most women were recruited from the University of Salzburg (Department of Biology, Department of Psychology) and gave their written informed consent. Participants were free of medication and reported no history of neurological disorders. Our studies were approved by the local ethics committee.

4.2. Salivary sex hormone analysis {#s0045}
----------------------------------

Estradiol and progesterone were quantified using Demetitec Salivary Estradiol ELISA kids according to the recommendations of the provider. Each participant provided a saliva sample before an EEG-session. Saliva samples were collected in sterile centrifuge tubes, stored in a freezer at −20 °C. Particles in saliva samples were removed by centrifugation (2355 g for 15 min) before sex hormone quantification. [Tables 3 and 4](#t0015 t0020){ref-type="table"} summarize mean and standard deviation of estradiol and progesterone levels.

4.3. EEG recordings {#s0050}
-------------------

EEG signals were recorded while women sat in an armchair in a sound-attenuated room with eyes closed for five minutes. Women having a natural menstrual cycle were tested in early (onset of menstruation plus five days) and late follicular phase (approximately 14 days before onset of menstruation) as well as in luteal phase (three days post ovulation to five days before the onset of menstruation). Late follicular phase was estimated by verbal reports and by use of a commercial ovulation tests (Pregnafix^®^Ovulationstest). About a third of the participants started in early follicular phase, late follicular phase, and luteal phase, respectively. With six exceptions, the three EEG sessions were a maximum of one menstrual cycle apart. Women using hormonal contraceptives were tested twice, once during administration pause (inactive phase) and once during intake of the pill (active phase). About one half of the participants started in the active and the second half in the inactive phase.

4.4. Acquisition of EEG data {#s0055}
----------------------------

32 Ag--AgCl electrodes were used in study 1 and 64 Ag--AgCl electrodes were used in study 2 and study 3, respectively, to record EEG signals. Electrodes were referenced to a nose electrode and a grounding electrode was located on the forehead. Electrode positions were according to the 10--20 system ([@bib19]). Signals were amplified with a BrainAmp amplifier (Brain Products, Inc., Gilching, Germany) using a sampling rate at 1000 Hz. To eliminate 50 Hz oscillation, a notch filter at 50 Hz was applied and recording bandwidth was set from .016 to 100 Hz. Eye movements were controlled by two electrodes set at vertical and horizontal positions near the right eye. Impedance was kept below 8 kΩ.

### 4.4.1. Data-analysis {#s0060}

EEG data were analyzed using BrainVisionAnalyzer 2.0 (Brain Products, Inc., Gilching, Germany). Raw EEG data were re-referenced to earlobe-electrodes and filtered with an IIR bandpass filter between .5 and 40 Hz in study 1 or .5 and 70 Hz in study 2 and study 3, respectively. Eye artifacts (EOG) were removed using ocular correction based on Gratton and Coles ([@bib13]). Remaining artifacts were eliminated by skipping bad intervals following visual inspection.

### 4.4.2. Individual alpha frequency and gravity frequency {#s0065}

Alpha frequency is characterized either as peak or gravity frequency within the traditional alpha frequency band of about 8--12 Hz. Peak frequency was estimated as the spectral component within *f*1 to *f*2 which showed the largest power. To calculate the individual alpha frequency (IAF) and the center frequency, respectively, we segmented five minutes resting-conditions eyes closed into consecutive 4000 ms segments and applied a Fast-Fourier-Transformation (FFT) with a .24 Hz resolution using the Hanning window (10%). After averaging, we inspected visually the highest peak of the Po3, Po4, P3 and P4 electrodes within a frequency window from 7 to 14 Hz and noted the peak frequency (IAF). We choose a similar frequency window as [@bib4] used. Center or gravity frequency is the weighted sum of spectral estimates, divided by alpha power (∑(*a*(*f*)×*f*))/(∑*a*(*f*))×*a*(*f*) is power spectral estimate at frequency *f*. Summation ranges from *f*1 to *f*2. Gravity or center frequency is more appropriate when multiple peaks are detected in the alpha range ([@bib21]). We calculated the center frequency using MATLAB (R2010b). The frequency window *f*1 to *f*2 was defined collectively for each cycle phase or pill intake phase and pill free week as the mean IAF±2 Hz. For example if the mean IAF during early follicular phase is 10.06 Hz than *f*1 is 8.06 Hz and *f*2 is 12.06 Hz.

4.5. Statistical methods {#s0070}
------------------------

PASW Statistics 18 (SPSS) was used for statistical analysis. To test for cycle-dependent differences in center frequency or IAF, a repeated measure ANOVA with the factor IAF or center frequency was calculated separately for each electrode. Dependent *t*-tests showed differences in center frequency or IAF between individual cycle phases and independent *t*-tests showed differences between naturally cycling women and women using oral contraceptives. Estradiol levels were associated with center frequency or IAF using the Pearson correlation coefficient (2-tailed).
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![Average alpha center frequency (M±SD) in women with a natural menstrual cycle and women using oral contraceptives. Late follicular women show lowest center frequency. EFP: early follicular phase, LFP: late follicular phase, LP: luteal phase; pill intake phase: active phase, pill free week: inactive phase; ^\*^*p*\<.05; ^\*\*^*p*\<.01.](gr1){#f0005}

![Average IAF (M±SD) in women with a natural menstrual cycle and women using oral contraceptives. Late follicular women reveal lowest IAF. EFP: early follicular phase, LFP: late follicular phase, LP: luteal phase; pill intake phase: active phase, pill free week: inactive phase; ^\*^*p*\<.05; ^\*\*^*p*\<.01.](gr2){#f0010}

![Estradiol level correlates negatively with alpha frequency. (A) The regression line shows a negative correlation between estradiol and center frequency in luteal woman. (B) Alpha oscillation (filtered between 7 and 14 Hz) from late follicular women having either a low estradiol or high estradiol level.](gr3){#f0015}

###### 

Women with a natural menstrual cycle.

            *N*   Age range   Mean age±SD   Mean cycle length   Schedule of studies (modus[a](#tbl1fna){ref-type="table-fn"})
  --------- ----- ----------- ------------- ------------------- ---------------------------------------------------------------
  Study 1   18    16--33      24.06±4.66    29.44±1.9           September to March (December).
  Study 2   19    19--30      23.32±3.45    27.97±2.32          December to April (February)
  Study 3   20    19--29      24.80±2.82    30.23±2.47          April to October (October)

In study 1, we excluded two women because they had no menstruation since one year and two because of technical problems. For correlational analyses between sex hormones and IAF, one subject was excluded in the late follicular and luteal phase because her estradiol level was more than two standard deviations higher than the mean. In study 2, one subject was excluded because she did not finish the study. For correlational analyses between sex hormones and IAF one subject was excluded in the early follicular and one subject in the late follicular phase because their estradiol level was more than two standard deviations higher than the mean. Furthermore, one subject was excluded in the late follicular and luteal phase and one subject in the luteal phase because their progesterone level was more than two standard deviations higher than the mean. In study 3, one woman was excluded during luteal phase because of inadequate determination of luteal phase. For correlational analyses between sex-hormones and IAF we excluded one participant in each cycle phase because her saliva sample was contaminated with lipstick. One woman was excluded during late follicular and luteal phase because her progesterone level was more than two standard deviations higher than the mean. Furthermore, we had one missing values of progesterone level during early follicular phase because it was too high and, therefore, not quantifiable.

modus: month, in which most women were studied.

###### 

Women using oral contraceptives (combination pill).

            N    Age range   Mean age±SD   Oral contraceptives                                                                                                                         Schedule of studies (modus[a](#tbl2fna){ref-type="table-fn"})
  --------- ---- ----------- ------------- ------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------
  Study 1   17   19--26      22.53±2.27    Desogestrel (*n*=2), Gestoden (*n*=2), Dienogest (*n*=4), Drospirenon (*n*=8), Levonorgestrel (*n*=1)                                       October to March (January)
  Study 2   20   18--26      21.60±2.19    Desogestrel (*n*=1), Gestoden (*n*=3), Dienogest (*n*=3), Drospirenon (*n*=8), Levonorgestrel (*n*=2), Cyproteron (*n*=3)                   November to March (January)
  Study 3   20   20--28      23±2.03       Desogestrel (*n*=1), Gestoden(*n*=2), Dienogest(*n*=4), Drospirenon(*n*=8), Levonorgestrel(*n*=3), Cyproteron(*n*=1), Chlormadinon(*n*=1)   April to October (July)

Combined oral contraceptive pill contained ethinylestradiol (.015--.035 mg) and different doses of progestins. In study 1, two women were excluded because they use different hormonal contraceptives then the classical combined contraceptive pill and other three because of technical problems. In study 2, one subject was excluded because she did not finished the study. For correlational analyses between sex-hormones and IAF one subject was excluded during pill intake and pill free week because her progesterone level was more than two standard deviations higher than the mean. In study 3, one subject was excluded because she did not finished the study. One more participant was excluded because she is a diabetic and need to regularly inject insulin. For correlational analyses between sex-hormones and IAF two participants were excluded during pill free week because their progesterone level were more than two standard deviations higher than the mean. Furthermore we had one missing values of progesterone level during pill intake phase because it was too high and therefore impossible to measure.

modus: month, in which most women were studied.

###### 

Mean±SD for estradiol- (E~2~) and progesterone-level (P) (in pg/ml) for early follicular phase (EFP) late follicular phase (LFP) and luteal phase (LP).

            EFP                  LFP                      LP                                                                 
  --------- -------------------- ------------------------ -------------------- ----------------------- --------------------- ------------------------
  Study 1   *n* (18) 3.94±1.82   *n* (18) 62.34±57.74     *n* (17) 4.43±2.07   *n* (17) 64.76 ±32.21   *n* (17) 4.26±1.42    *n* (17) 134.67±105.94
  Study 2   *n* (18) 5.42±2.05   *n* (18) 131.15±101.35   *n* (17) 7.50±2.43   *n* (17) 193.04±87.61   *n* (17) 6.74 ±3.20   *n* (17) 334.43±104.38
  Study 3   *n* (19) 8.46±4.13   *n* (18) 87.74±54.72     *n* (18) 9.81±3.91   *n* (18) 95.19±81.66    *n* (17) 9.02±3.90    *n* (17) 290.79±177.45

###### 

Mean±SD for estradiol- (E~2~) and progesterone-level (P) (in pg/ml) for pill intake phase and pill free week.

            Pill intake phase     Pill free week                                 
  --------- --------------------- ------------------------ --------------------- -----------------------
            *E*~2~                P                        E~2~                  P
                                                                                 
  Study 1   *n* (17) 3.09±1.84    *n* (17) 171.61±138.66   *n* (17) 3.86±2.18    *n* (17) 137.35±62.93
  Study 2   *n* (19) 4.19±1.56    *n* (19) 77.66±54.57     *n* (19) 4.49±1.55    *n* (19) 71.45±33.37
  Study 3   *n* (20) 10.91±4.60   *n* (19) 123.16±80.49    *n* (18) 10.01±4.08   *n* (18) 85.23±53.57
